Researchers have been excited about the medication , a novel dual treatment showing remarkable outcomes in early trials for body loss . It works by modulating two systems: GLP-1 and GIP, that , when stimulated, support control appetite and boost calorie burn. Early reports suggest noteworthy body management and potential benefits for people facing